Biologics for the Spine and Sacroiliac Joint Complex - What is the Background, Evidence, and Clinical Applications?-Biologics for the Spine and Sacroiliac Joint Complex - What is the Background, Evidence, and Clinical Applications?

Biologics for the Spine and Sacroiliac Joint Complex - What is the Background, Evidence, and Clinical Applications?

Video Transcription

Video Summary

In this video, the importance of patient selection for biologics of the spine is emphasized. It is crucial to carefully select patients who will benefit from these therapies, as not all patients experience the same level of success with biologics. Regulatory issues surrounding biologics also impact patient selection, and healthcare professionals should be familiar with FDA guidelines and regulations to ensure safety and efficacy. The cost of biologics should be considered, as they can be expensive and may not be covered by insurance. Open discussions with patients about potential costs and exploring alternative options if necessary are important. The lack of robust data and variability in what different practices offer to patients is discussed, highlighting the importance of informed consent. The speaker presents a case of a patient offered stem cell injections for back pain after multiple spinal surgeries, emphasizing the need to consider appropriateness for each individual. Challenges in identifying the right patient for biologic therapies in specific joints are mentioned and the need for further research is highlighted. The issue of cost and variability in pricing structures for biologic therapies is addressed, as well as the importance of staying updated on FDA regulations and using appropriate nomenclature for biologics.

Keywords

patient selection

biologics of the spine

regulatory issues

FDA guidelines

cost of biologics

insurance coverage

open discussions

informed consent

stem cell injections

specific joints

pricing structures